Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Philippe Astoul (Marseille, France). Empyema: How to prevent progression to stage III disease. ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019

Member's Comments

No comment yet.

Related content which might interest you: How to prevent progression to stage III disease Source: International Congress 2016 – An update on pleural empyema diagnostics and treatment Year: 2016 Stage IV sarcoidosis: comparison of survival with the general population and causes of death Source: Eur Respir J 2011; 38: 1368-1373 Year: 2011 Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003 Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Managing end stage disease in ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Managing end stage disease in ILDs Source: ERS Course 2016 Year: 2016 Monitoring disease progression in COPD patients: one step beyond! Source: Eur Respir J 2014; 43: 665-667 Year: 2014 COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Pulmonary malakoplakia: a rare presentation mimicking extensive stage IV lung cancer Source: Eur Respir J 2011; 38: 983-985 Year: 2011 Systemic inflamation and prognosis in lung cancer stage I-II Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Time lost for diagnostics of lung carcinoma related to disease stage and prognosis Source: Eur Respir J 2004; 24: Suppl. 48, 297s Year: 2004 Cytomegalovirus: an unrecognised potential contributor to cystic fibrosis disease progression? Source: Eur Respir J, 53 (4) 1801727; 10.1183/13993003.01727-2018 Year: 2019 Heterogeneity of stage III and its implication on treatment Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 How to manage a patient with COPD - early identification and how to prevent progression Source: ERS Satellites 2021 Year: 2021 Comorbidities in stage IV COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 NSCLC stage IV Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 The role of determining the levels of collagen type IV in the management of patients with severe chronic obstructive pulmonary disease – Focus on roflumilast Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Delays in the diagnosis and treatment of primary lung cancer: are longer delays associated with advanced pathological stage? Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Late stage of experimental pulmonary fibrosis is modulated by collagen V Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012